In this educational webinar, ILD respirologists Dr. Amanda Grant-Orser and Dr. Kerri Johannson discuss how genetics can be an important tool for patients with ILD, shared the results of a recent national patient survey for which many people within the CPFF community participated, and explained genetic testing in Canada.
Dr. Amanda Grant-Orser
Dr. Amanda Grant-Orser is a recipient of the 2020 CPFF Robert Davidson Fellowship. She is currently a clinical fellow with the Interstitial Lung Disease Program at the University of Calgary, under the mentorship of Dr. Kerri Johansson and Dr. Charlene Fell.
Her clinical interests include CTD-ILD and familial PF. Dr. Grant-Orser’s current research focuses on understanding patient values and perceptions regarding genetic testing for ILD. She is also exploring the feasibility and efficacy of treating lung disease in the era of telemedicine.
Dr. Kerri Johannson
Dr. Kerri Johannson is Clinical Associate Professor in the Departments of Medicine and Community Health Sciences at the University of Calgary, and is a member of the Snyder Institute for Chronic Diseases. She is Research Director for the Interstitial Lung Disease program at South Health Campus and Director of the ILD Fellowship program.